Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing

AE Kabakov, AO Yakimova - Cancers, 2021 - mdpi.com
Simple Summary Some regions of aggressive malignancies experience hypoxia due to
inadequate blood supply. Cancer cells adapting to hypoxic conditions somehow become …

Factors and molecular mechanisms of radiation resistance in cancer cells

JC Alamilla-Presuel, AM Burgos-Molina… - … Journal of Radiation …, 2022 - Taylor & Francis
Purpose The aim of this work is to review the published studies on radiation resistance
mechanisms and molecular markers involved in different tumors. The revision has been …

High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

Q Huo, J Wang, N Xie - BMC cancer, 2023 - Springer
Background Heat shock protein beta-1 (HSPB1) is a crucial biomarker for pathological
processes in various cancers. However, the clinical value and function of HSPB1 in breast …

[HTML][HTML] Iron metabolism: State of the art in hypoxic cancer cell biology

S Liu, X Cao, D Wang, H Zhu - Archives of Biochemistry and Biophysics, 2022 - Elsevier
The tumor microenvironment (TME) promotes the malignant transformation of cancer cells,
mainly through metabolic reprogramming. As one of the most prominent features of the TME …

Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma

Y Rajesh, A Biswas, U Kumar… - Proceedings of the …, 2020 - National Acad Sciences
Glioblastoma multiforme (GBM) is an aggressive cancer without currently effective therapies.
Radiation and temozolomide (radio/TMZ) resistance are major contributors to cancer …

Prognosis and immune landscapes in glioblastoma based on gene-signature related to reactive-oxygen-species

P Kaushal, J Zhu, Z Wan, H Chen, J Ye, C Luo - NeuroMolecular Medicine, 2023 - Springer
Glioblastoma (GBM) is the most malignant and aggressive primary brain tumor and is highly
resistant to current therapeutic strategies. Previous studies have demonstrated that reactive …

Transcription factor Fli-1 as a new target for antitumor drug development

L Li, J Yu, S Cheng, Z Peng, H Luo - International Journal of Biological …, 2022 - Elsevier
The transcription factor Friend leukemia virus integration 1 (Fli-1) belonging to the E26
Transformation-Specific (ETS) transcription factor family is not only expressed in normal …

FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway

E Chen, J Huang, M Chen, J Wu, P Ouyang… - Journal of Translational …, 2023 - Springer
Background Radiotherapy resistance is the main cause of treatment failure in
nasopharyngeal carcinoma (NPC), which leads to poor prognosis. It is urgent to elucidate …

Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma

A Biswas, Y Rajesh, S Das, I Banerjee, N Kapoor… - Cancer Letters, 2022 - Elsevier
Fusion genes are abnormal genes resulting from chromosomal translocation, insertion,
deletion, inversion, etc. ETV6, a rather promiscuous partner forms fusions with several other …

The potential crosstalk genes and molecular mechanisms between glioblastoma and periodontitis

J Huang, Y Chen, Y Kang, Z Yao, J Song - Scientific Reports, 2024 - nature.com
Despite clinical and epidemiological evidence suggestive of a link between glioblastoma
(GBM) and periodontitis (PD), the shared mechanisms of gene regulation remain elusive. In …